Company news
Idexx Laboratories, Inc. (NASDAQ:IDXX) news
Idexx Laboratories, Inc. news releases on 6ix. Latest, Oct 1, 2026: IDEXX Laboratories to Release 2026 Third Quarter Financial Results
Press releases & updates
IDEXX Laboratories to Release 2026 Third Quarter Financial Results
October 1, 2026
Chicago Pacific Founders Pet Fund Announces Exit of CoVetAI Following Acquisition by IDEXX Laboratories
September 30, 2026
Chicago Pacific Founders Pet Fund Announces Exit of CoVetAI Following Acquisition by IDEXX Laboratories
September 29, 2026
IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection
September 17, 2026
IDEXX Laboratories Acquires CoVetAI to Advance Veterinary Workflow Intelligence
September 16, 2026
IDEXX Laboratories to Participate in Morgan Stanley 24th Annual Global Healthcare Conference
August 31, 2026
IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test
August 11, 2026
IDEXX Laboratories : Earnings snapshot Q2 2026
August 4, 2026
IDEXX Releases 2025 Corporate Responsibility Report, Highlighting Progress Against Its Goals
July 28, 2026
IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection
May 26, 2026
IDEXX SDMA Now Integrated into the Most Common Catalyst Chemistry Profiles
May 18, 2026
IDEXX Laboratories to Present at Stifel Conference and Announces 2026 Investor Day
May 14, 2026
IDEXX Laboratories : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q)
May 5, 2026
IDEXX Laboratories : Earnings snapshot Q1 2026
May 5, 2026
Idexx: Q1 Earnings Snapshot
May 5, 2026
University of New England launches new Institute of Public and Planetary Health in honor of philanthropist and IDEXX Founder David Evans Shaw
April 27, 2026
IDEXX Laboratories to Release 2026 First Quarter Financial Results
April 7, 2026
IDEXX Announces UK Availability of Cancer Dx Panel for Early Detection of Canine Lymphoma
March 31, 2026
IDEXX Laboratories : Raymond James Institutional Investors Conference Presentation
March 2, 2026
IDEXX Laboratories to Present at Two Institutional Investor Conferences
February 12, 2026
IDEXX Laboratories Announces Fourth Quarter and Full Year 2025 Results
February 2, 2026
Lowest-Dose Radiography Meets Next-Level Imaging: IDEXX Launches ImageVue DR50 Plus
January 15, 2026
IDEXX Advances the Future of Veterinary Cancer Care with Comprehensive Mast Cell Tumor Testing for Dogs
January 14, 2026
IDEXX Announces CEO Succession
January 13, 2026
IDEXX Laboratories to Release 2025 Fourth Quarter and Full Year Financial Results
January 9, 2026
IDEXX Laboratories Announces Third Quarter Results
November 2, 2025
Bonsai Health Names ModMed Veteran Rick Trefzger Chief Revenue Officer
October 16, 2025
IDEXX Laboratories to Release 2025 Third Quarter Financial Results
October 7, 2025
IDEXX Laboratories Elects Karen Peacock to Board of Directors
October 6, 2025
ImmuCell Announces Selection of its Next President and CEO
September 29, 2025
IDEXX Laboratories to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference
September 1, 2025
National Veterinary Associates Welcomes Brian McKeon to Board of Directors
August 18, 2025
IDEXX Laboratories Announces Second Quarter Results
August 3, 2025
IDEXX Releases 2024 Corporate Responsibility Report, Highlighting Progress Against Its Goals
July 29, 2025
IDEXX Laboratories Elects Joseph L. (Jay) Hooley to Board of Directors
July 9, 2025
IDEXX Laboratories to Release 2025 Second Quarter Financial Results
June 23, 2025
Third Expansion of IDEXX's Catalyst Platform in Under a Year Delivers Critical Insights to Veterinarians Evaluating Canine Patients for Endocrine Disorders
June 4, 2025
IDEXX Laboratories to Present at Stifel Conference and Announces 2025 Investor Day
May 12, 2025
IDEXX Laboratories Announces First Quarter Results
April 30, 2025
IDEXX Laboratories to Release 2025 First Quarter Financial Results
April 2, 2025
IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences
February 12, 2025
IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results
February 2, 2025
IDEXX Announces Groundbreaking Cancer Dx Panel with Affordable Early Detection Test for Canine Lymphoma
January 22, 2025
IDEXX Laboratories to Release 2024 Fourth Quarter and Full Year Financial Results
January 15, 2025
IDEXX Laboratories Announces Increase in Share Repurchase Program Authorization
December 8, 2024
IDEXX Announces CFO Transition
November 20, 2024
CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results
October 30, 2024
IDEXX Laboratories to Release 2024 Third Quarter Financial Results
September 29, 2024
IDEXX Laboratories to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
August 20, 2024
IDEXX Releases 2023 Corporate Responsibility Report, Highlighting Progress Against Its Goals
July 29, 2024